BCGitis detected by (18)F-FDG PET/CT after treatment of bladder urothelial carcinoma

Rev Esp Med Nucl Imagen Mol. 2016 Mar-Apr;35(2):141-2. doi: 10.1016/j.remn.2015.09.003. Epub 2015 Oct 27.

Authors

G A Jiménez Londoño¹, A M García Vicente², J Ros Izquierdo³, M J Tello Galán², B González García², F J Pena Pardo², A Palomar Muñoz², Á M Soriano Castrejón²

Affiliations

¹ Nuclear Medicine Department, General University Hospital of Ciudad Real, Spain. Electronic address: gjimenez91@yahoo.com.
² Nuclear Medicine Department, General University Hospital of Ciudad Real, Spain.
³ Internal Medicine Department, General University Hospital of Ciudad Real, Spain.

PMID: 26522000
DOI: 10.1016/j.remn.2015.09.003

No abstract available

Publication types

Case Reports

MeSH terms

Adjuvants, Immunologic / therapeutic use*
BCG Vaccine / therapeutic use*
Carcinoma, Transitional Cell / therapy*
Fever of Unknown Origin / diagnostic imaging
Fever of Unknown Origin / etiology*
Fluorodeoxyglucose F18
Humans
Male
Neoplasm Recurrence, Local / therapy*
Positron Emission Tomography Computed Tomography*
Radiopharmaceuticals
Tuberculosis / complications*
Tuberculosis / diagnostic imaging
Urinary Bladder Neoplasms / therapy*

Substances

Adjuvants, Immunologic
BCG Vaccine
Radiopharmaceuticals
Fluorodeoxyglucose F18